Super Nutrient that Generates Energy in Your Energy Cells!
REFERENCES:
1. Coenzyme q10 therapy - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/25126052
2. Clinical applications of coenzyme Q10 - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24389208
3. Ubiquinol: an endogenous antioxidant in aerobic organisms - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1993. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/8241707
4. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/25282031
5. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1993. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/8241697
6. Coenzyme Q10 for the treatment of heart failure: a review of the literature - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2015. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/26512330
7. Contemporary Drug Development in Heart Failure: Call for Hemodynamically Neutral Therapies - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2015. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/26199309
8. Oxidative stress and antioxidants in exercise - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2001. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/11375753
9. Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2012. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/23182644
10. Functional diagnostics in mitochondrial diseases - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2007. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/17492503
11. Oxidative stress and antioxidant defense in plasma after repeated bouts of supramaximal exercise: the effect of coenzyme Q10 - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/21681167/
12. A randomized trial of coenzyme Q10 in mitochondrial disorders - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/20886510/
13. The effects of coenzyme Q10 supplementation on performance during repeated bouts of supramaximal exercise in sedentary men - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/19644406/
14. Antifatigue effects of coenzyme Q10 during physical fatigue - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2008. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/18272335/
15. Effects of acute and 14-day coenzyme Q10 supplementation on exercise performance in both trained and untrained individuals - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2008. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/18318910/
16. An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1999. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/9974149
17. The plasma membrane redox system is impaired by amyloid β-peptide and in the hippocampus and cerebral cortex of 3xTgAD mice - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/20673763
18. Parkinson’s disease: mitochondrial molecular pathology, inflammation, statins, and therapeutic neuroprotective nutrition - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2010. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/20702843
19. Evaluation of coenzyme Q as an antioxidant strategy for Alzheimer’s disease - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2008. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/18560133
20. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2002. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/12374491
21. Mitochondrial dysfunction in migraine - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2013. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24331360
22. A randomized, double-blinded, placebo-controlled, crossover, add-on study of CoEnzyme Q10 in the prevention of pediatric and adolescent migraine - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/21586650
23. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2005. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/15728298
24. Coenzyme Q10 deficiency and response to supplementation in pediatric and adolescent migraine - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2007. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/17355497
25. Effectiveness of coenzyme Q10 in prophylactic treatment of migraine headache: an open-label, add-on, controlled trial - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2017. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/27670440
26. Coenzyme Q10 Improves Lipid Metabolism and Ameliorates Obesity by Regulating CaMKII-Mediated PDE4 Inhibition - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2017. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/28811612
27. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24586567
28. Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2009. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/19530339
29. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1999. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/10416046
30. Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/21467235/
31. Activities of vitamin Q10 in animal models and a serious deficiency in patients with cancer - PubMed. PubMed. www.ncbi.nlm.nih.gov; 1997. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/9177262/
32. Plasma coenzyme Q10 levels and prostate cancer risk: the multiethnic cohort study - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/21297042
33. Oxidative stress and antioxidants in disease and cancer: a review - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2014. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/24969860
34. Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients--markers for risk assessment? - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/22126471
35. Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients--markers for risk assessment? - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2011. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/22126471
36. Recombinant interferon alpha-2b and coenzyme Q10 as a postsurgical adjuvant therapy for melanoma: a 3-year trial with recombinant interferon-alpha and 5-year follow-up - PubMed. PubMed. www.ncbi.nlm.nih.gov; 2007. [accessed 6 Jul 2022] Available from: https://www.ncbi.nlm.nih.gov/pubmed/17505263
